DEA published its 2024 National Drug Threat Assessment that examined the trends in deaths from certain drugs, the number of seizures documented, and more. The assessment also noted that between 2021 and 2023, DEA found an increasing number of fraudulent electronic prescriptions (e-scripts) for controlled prescription drugs, with DEA registrants reporting that their registration numbers and identities were used to create fake e-scripts. DEA described their efforts to disrupt drug trafficking networks through initiatives such as Operation Overdrive and Operation OD Justice, as well as the agency’s community outreach efforts to raise awareness about the dangers of fentanyl and counterfeit pills. The document can be found here.
